Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) EBIT Margin (2025)

Centessa Pharmaceuticals has reported EBIT Margin over the past 1 years, most recently at 205.18% for Q1 2025.

  • Quarterly EBIT Margin changed N/A to 205.18% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 1384.61% through Dec 2025, changed N/A year-over-year, with the annual reading at 1384.61% for FY2025, N/A changed from the prior year.
  • EBIT Margin was 205.18% for Q1 2025 at Centessa Pharmaceuticals.
  • Over five years, EBIT Margin peaked at 205.18% in Q1 2025 and troughed at 205.18% in Q1 2025.